| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,500 | $166.67 | $416,669.74 | -1.0% | - | - | |
| Sep 2, 2025 | A Agilent Technologies, Inc. | McDonnell Padraig | President And CEO | Sell | 2,000 | $124.88 | $249,760.00 | -5.6% | - | - | |
| Sep 2, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 1,339 | $23.93 | $32,042.27 | -2.0% | - | - | |
| Sep 2, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 5,079 | $166.53 | $845,795.04 | -1.0% | - | - | |
| Sep 2, 2025 | XGN Exagen Inc. | Black Jeffrey G. | Chief Financial Officer | Sell | 20,466 | $9.79 | $200,362.14 | -7.1% | - | - | |
| Sep 2, 2025 | NOTV Inotiv, Inc. | Neff R Matthew | Director | Sell | 2,000 | $1.67 | $3,337.60 | -1.3% | - | - | |
| Sep 2, 2025 | GH Guardant Health, Inc. | Joyce Meghan V. | Director | Sell | 100 | $65.84 | $6,584.00 | -0.9% | - | - | |
| Sep 2, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 378 | $125.81 | $47,556.03 | -8.4% | - | - | |
| Sep 2, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J. | CEO | Sell | 37,393 | $475.87 | $17,794,383.07 | -2.0% | - | - | |
| Aug 29, 2025 | BDSX Biodesix Inc | Schuler Jack W | - | Buy | 3,488,372 | $0.43 | $1,499,999.96 | +16.7% | - | - | |
| Aug 29, 2025 | TMO Thermo Fisher Scientific Inc. | Holmes Joseph R. | VP &Chief Accounting Officer | Sell | 385 | $492.63 | $189,661.91 | -7.3% | +19.9% | - | |
| Aug 28, 2025 | NTRA Natera, Inc. | Chapman Rowan E | Director | Sell | 2,750 | $166.99 | $459,222.50 | -31.4% | - | - | |
| Aug 27, 2025 | RDNT Radnet, Inc. | Hames Norman R | Pres And Coo-west Operations | Sell | 5,000 | $71.10 | $355,500.00 | -20.1% | - | - | |
| Aug 27, 2025 | WGS Genedx Holdings Corp. | Ryan Jason | Director | Sell | 21,358 | $127.76 | $2,728,690.90 | -5.7% | - | - | |
| Aug 27, 2025 | RVTY Revvity, Inc. | Michas Alexis P | Director | Sell | 500 | $89.01 | $44,505.00 | -6.4% | - | - | |
| Aug 27, 2025 | CSTL Castle Biosciences Inc | Oelschlager Kristen M | Chief Operating Officer | Sell | 12,677 | $22.02 | $279,134.86 | -8.2% | - | - | |
| Aug 27, 2025 | CSTL Castle Biosciences Inc | Oelschlager Kristen M | Chief Operating Officer | Sell | 18,007 | $21.69 | $390,571.83 | -10.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.